Hangzhou Chance Pharmaceuticals
A clinical-stage biotechnology company focusing on discovering.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD185—278m (Dealroom.co estimates Oct 2021.)
Hangzhou City Zhejiang (HQ)
Authorizing premium user...